Emmaus Life Sciences Reports Additional Positive Preliminary Results in Diverticulosis Pilot Trial

Stock Information for Emmaus Life Sciences Incorporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Emmaus Life Sciences Incorporation

Emmaus Life Sciences Reports Delayed Filing of Annual Report
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences Reports Q3 2023 Financial Results
Emmaus Life Sciences Reports Management Changes
Emmaus Life Sciences Reports Q2 2023 Financial Results
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.